UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long-term survival in patients with advanced non–small-cell lung cancer treated with atezolizumab versus docetaxel: Results from the randomised phase III OAK study

European journal of cancer (1990), 2019-01, Vol.107, p.124-132

2019

Volltextzugriff (PDF)

A phase 1 study of MM-141, a novel tetravalent monoclonal antibody targeting IGF-1R and ErbB3, in relapsed or refractory solid tumors

European journal of cancer (1990), 2016-12, Vol.69, p.S137-S138

2016

Volltextzugriff (PDF)

338 Results from a phase 1 study of ARQ 092, a novel pan AKT-inhibitor, in subjects with advanced solid tumors or recurrent malignant lymphoma

European journal of cancer (1990), 2015-09, Vol.51, p.S66-S66

2015

Volltextzugriff (PDF)

Maximum Liquefaction of Gases Revisited

International Journal of Thermodynamics, 2022-01, Vol.25 (2), p.8-14

2022

Volltextzugriff (PDF)

A randomized, phase II trial of two dose schedules of carboplatin/paclitaxel/cetuximab in stage IIIB/IV non-small-cell lung cancer (NSCLC)

Annals of oncology, 2009-06, Vol.20 (6), p.1068-1073

2009

Volltextzugriff (PDF)

Malonic acid: A potential reagent in decontamination processes for Ni-rich alloy surfaces

Journal of nuclear materials, 2011-05, Vol.412 (1), p.72-81

2011

Volltextzugriff (PDF)

Multiplex polymerase chain reaction and ligation detection reaction/universal array technology for the traceability of genetically modified organisms in foods

Analytical biochemistry, 2005-11, Vol.346 (1), p.90-100

2005

Volltextzugriff (PDF)

Analysis of zirconium oxide formed during oxidation at 623 K on Zr–2.5Nb and Zircaloy-4

Materials science & engineering. A, Structural materials : properties, microstructure and processing, 2004-09, Vol.381 (1), p.104-112

2004

Volltextzugriff (PDF)

Draft Genome Sequence of the Host-Restricted Salmonella enterica Serovar Abortusovis Strain SS44

Genome announcements (Washington, DC), 2014-04, Vol.2 (2)

2014

Volltextzugriff (PDF)

114TiP KEYNOTE-B99: Phase II study of pembrolizumab plus investigational agents combined with chemotherapy as first-line therapy for extensive-stage small cell lung cancer (ES-SCLC)

Annals of oncology, 2021-12, Vol.32, p.S1425

2021

Volltextzugriff (PDF)

P1.16-48 Experiences of Pts on 1st Line Care (EP1C): Symptoms and Impacts of EGFR TKI Therapy on Real-World Daily Lives of NSCLC Pts

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S606-S607

2019

Volltextzugriff (PDF)

451O Preliminary evidence of clinical activity from phase I and Ib trials of the CLK/DYRK inhibitor cirtuvivint (CIRT) in subjects with advanced solid tumors

Annals of oncology, 2022-09, Vol.33, p.S742-S743

2022

Volltextzugriff (PDF)

375O Final efficacy results from IMpower132: First-line atezolizumab + chemotherapy in patients with stage IV non-squamous NSCLC

Annals of oncology, 2020-11, Vol.31, p.S1386-S1387

2020

Volltextzugriff (PDF)

Deep sequencing reveals double mutations in cis of MPL exon 10 in myeloproliferative neoplasms

Haematologica (Roma), 2011-04, Vol.96 (4), p.607-611

2011

Volltextzugriff (PDF)

Molecular characterization and chromosomal mapping of melanoma growth stimulatory activity, a growth factor structurally related to beta‐thromboglobulin

The EMBO journal, 1988-07, Vol.7 (7), p.2025-2033

1988

Volltextzugriff (PDF)

Investigation of the multiple anchors approach in oligonucleotide microarray preparation using linear and stem-loop structured probes

Nucleic acids research, 2002-04, Vol.30 (8), p.E34-34

2002

Volltextzugriff (PDF)

420 - A phase 1 study of MM-141, a novel tetravalent monoclonal antibody targeting IGF-1R and ErbB3, in relapsed or refractory solid tumors

European journal of cancer (1990), 2016-12, Vol.69, p.S137-S138

2016

Volltextzugriff (PDF)

Association between immune-related adverse events (irAEs) and atezolizumab efficacy in advanced NSCLC: analyses from the phase III study OAK

Annals of oncology, 2017-09, Vol.28, p.v469

2017

Volltextzugriff (PDF)

Results of a randomized, placebo-controlled, phase 2 study of tarextumab (TRXT, anti-Notch2/3) in combination with etoposide and platinum (EP) in patients (pts) with untreated extensive-stage small-cell lung cancer (ED-SCLC)

Annals of oncology, 2017-09, Vol.28, p.v540

2017

Volltextzugriff (PDF)

Immune-related adverse events (irAEs) in advanced NSCLC patients treated with atezolizumab: Safety population analyses from the Ph III study OAK

Annals of oncology, 2017-09, Vol.28, p.v468

2017

Volltextzugriff (PDF)

P1.01-052 Patient-Reported Outcomes (PROs) in OAK: A Phase III Study of Atezolizumab vs Docetaxel in Non-Small-Cell Lung Cancer (NSCLC)

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S1914-S1915

2017

Volltextzugriff (PDF)

OA05.07 IMpower132: PFS and Safety Results with 1L Atezolizumab + Carboplatin/Cisplatin + Pemetrexed in Stage IV Non-Squamous NSCLC

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S332-S333

2018

Volltextzugriff (PDF)

Growth and characterization of oxide layers on zirconium alloys

Journal of nuclear materials, 1996-04, Vol.229 (1-3), p.79-92

1996

Volltextzugriff (PDF)

Development of a Universal Microarray Based on the Ligation Detection Reaction and 16S rRNA Gene Polymorphism To Target Diversity of Cyanobacteria

Applied and Environmental Microbiology, 2004-12, Vol.70 (12), p.7161-7172

2004

Volltextzugriff (PDF)

OA 17.07 Long-Term Survival in Atezolizumab-Treated Patients with 2L+ NSCLC from Ph III Randomized OAK Study

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S1794-S1794

2017

Volltextzugriff (PDF)

1 – 25 von 471

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(413)
Mit Volltextzugriff
(361)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(276)
Life Sciences & Biomedicine
(205)
Humans
(169)
Female
(91)
Male
(90)
Physical Sciences
(63)
Middle Aged
(59)
Adult
(58)
Biological And Medical Sciences
(54)
Oncology
(52)
Aged
(47)
Medical Sciences
(43)
General & Internal Medicine
(32)
Physics
(32)
Hematology, Oncology And Palliative Medicine
(31)
Technology
(31)
Medicine, General & Internal
(30)
Adolescent
(27)
Aged, 80 And Over
(27)
Child
(27)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Long-term survival in patients with advanced non–small-cell lung cancer treated with atezolizumab versus docetaxel: Results from the randomised phase III OAK study

A phase 1 study of MM-141, a novel tetravalent monoclonal antibody targeting IGF-1R and ErbB3, in relapsed or refractory solid tumors

338 Results from a phase 1 study of ARQ 092, a novel pan AKT-inhibitor, in subjects with advanced solid tumors or recurrent malignant lymphoma

Maximum Liquefaction of Gases Revisited

A randomized, phase II trial of two dose schedules of carboplatin/paclitaxel/cetuximab in stage IIIB/IV non-small-cell lung cancer (NSCLC)

Malonic acid: A potential reagent in decontamination processes for Ni-rich alloy surfaces

Multiplex polymerase chain reaction and ligation detection reaction/universal array technology for the traceability of genetically modified organisms in foods

Analysis of zirconium oxide formed during oxidation at 623 K on Zr–2.5Nb and Zircaloy-4

Draft Genome Sequence of the Host-Restricted Salmonella enterica Serovar Abortusovis Strain SS44

114TiP KEYNOTE-B99: Phase II study of pembrolizumab plus investigational agents combined with chemotherapy as first-line therapy for extensive-stage small cell lung cancer (ES-SCLC)

P1.16-48 Experiences of Pts on 1st Line Care (EP1C): Symptoms and Impacts of EGFR TKI Therapy on Real-World Daily Lives of NSCLC Pts

451O Preliminary evidence of clinical activity from phase I and Ib trials of the CLK/DYRK inhibitor cirtuvivint (CIRT) in subjects with advanced solid tumors

375O Final efficacy results from IMpower132: First-line atezolizumab + chemotherapy in patients with stage IV non-squamous NSCLC

Deep sequencing reveals double mutations in cis of MPL exon 10 in myeloproliferative neoplasms

Molecular characterization and chromosomal mapping of melanoma growth stimulatory activity, a growth factor structurally related to beta‐thromboglobulin

Investigation of the multiple anchors approach in oligonucleotide microarray preparation using linear and stem-loop structured probes

420 - A phase 1 study of MM-141, a novel tetravalent monoclonal antibody targeting IGF-1R and ErbB3, in relapsed or refractory solid tumors

Association between immune-related adverse events (irAEs) and atezolizumab efficacy in advanced NSCLC: analyses from the phase III study OAK

Results of a randomized, placebo-controlled, phase 2 study of tarextumab (TRXT, anti-Notch2/3) in combination with etoposide and platinum (EP) in patients (pts) with untreated extensive-stage small-cell lung cancer (ED-SCLC)

Immune-related adverse events (irAEs) in advanced NSCLC patients treated with atezolizumab: Safety population analyses from the Ph III study OAK

P1.01-052 Patient-Reported Outcomes (PROs) in OAK: A Phase III Study of Atezolizumab vs Docetaxel in Non-Small-Cell Lung Cancer (NSCLC)

OA05.07 IMpower132: PFS and Safety Results with 1L Atezolizumab + Carboplatin/Cisplatin + Pemetrexed in Stage IV Non-Squamous NSCLC

Growth and characterization of oxide layers on zirconium alloys

Development of a Universal Microarray Based on the Ligation Detection Reaction and 16S rRNA Gene Polymorphism To Target Diversity of Cyanobacteria

OA 17.07 Long-Term Survival in Atezolizumab-Treated Patients with 2L+ NSCLC from Ph III Randomized OAK Study

Suchergebnisse filtern